New ultrasound dye could stop unnecessary emergency surgeries for ovarian torsion

NCT ID NCT06677554

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding a contrast dye to standard ultrasound can better diagnose adnexal torsion (twisted ovary) and reduce unnecessary emergency surgeries. Currently, about 3 in 10 women who have emergency surgery for suspected torsion do not actually have it. The trial will involve 256 women with strong suspicion of torsion, comparing standard care to standard care plus contrast-enhanced ultrasound. If successful, this could spare many women from unnecessary surgery and its risks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
SonoVue® (contrast agent for ultrasound)
What this could lead to
If successful, this could provide a reliable, non-surgical way to diagnose adnexal torsion, reducing unnecessary emergency surgeries and preserving fertility.
What could go wrong
This is a Phase 3 trial, but the technique is still being tested against standard care. The contrast agent may cause allergic reactions, and the results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADNEXAL TORSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Ovarian Torsion

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHRU Nancy - Maternité Régionale

    RECRUITING

    Nancy, France

  • CHU

    NOT_YET_RECRUITING

    Besançon, France

  • CHU

    NOT_YET_RECRUITING

    Dijon, France

  • CHU

    NOT_YET_RECRUITING

    Reims, France

  • CHU Hautepierre

    NOT_YET_RECRUITING

    Strasbourg, France

  • CMCO

    NOT_YET_RECRUITING

    Schiltigheim, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.